Avior Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-220
Closed -$37.6K 2495
2024
Q3
$37.8K Sell
220
-170
-44% -$28.1K ﹤0.01% 1215
2024
Q2
$60.1K Sell
390
-200
-34% -$30K ﹤0.01% 1030
2024
Q1
$90.7K Sell
590
-855
-59% -$130K ﹤0.01% 1004
2023
Q4
$228K Hold
1,445
0.01% 496
2023
Q3
$211K Hold
1,445
0.01% 510
2023
Q2
$221K Hold
1,445
0.01% 509
2023
Q1
$224K Buy
1,445
+42
+3% +$6.6K 0.02% 508
2022
Q4
$216K Sell
1,403
-2,157
-61% -$318K 0.02% 456
2022
Q3
$469K Hold
3,560
0.04% 284
2022
Q2
$482K Sell
3,560
-95
-3% -$13.1K 0.05% 259
2022
Q1
$545K Sell
3,655
-1
-0% -$148 0.05% 281
2021
Q4
$592K Buy
3,656
+259
+8% +$41.9K 0.05% 292
2021
Q3
$564K Buy
3,397
+3,277
+2,731% +$560K 0.05% 286
2021
Q2
$20K Sell
120
-152
-56% -$25.1K ﹤0.01% 647
2021
Q1
$43K Buy
+272
New +$46.6K ﹤0.01% 536

Other funds holding FBT

Avior Wealth Management's FBT Position: Q4 2024 in Review

Avior Wealth Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2024, closing a stake of 220 shares — an estimated $37.6K sold.

Avior Wealth Management first reported a position in FBT in Q1 2021 and held it in 15 quarters. The position peaked at $592K in Q4 2021. 256 funds tracked by Wall St. Rank hold FBT as of Q4 2024.

  • Avior Wealth Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2024 after selling out during the quarter.
  • Avior Wealth Management sold 220 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2024, an estimated $37.6K.
  • Avior Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2021 and held it in 15 quarters.
  • Avior Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $592K in Q4 2021.
  • 256 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2024.

Based on Avior Wealth Management's 13F filing for Q4 2024, filed 17 Jan 2025.